1. Adherence to Guidelines for Community-Acquired Pneumonia

   • Patricia D. Brown

   Leading Article 22 September 2012 Pages: 413 - 420

2. Economic Evaluations of Treatments for Systemic Fungal Infections

   • Simon Dixon
   • Emma McKeen
   • Suzy Paisley

   Review Article 22 September 2012 Pages: 421 - 433

   

3. Management and Costs of Treating Lung Cancer Patients in a University Hospital

   • Konstantin J. Dedes
   • Thomas D. Szucs
   • Rolf A. Stahel

   Original Research Article 22 September 2012 Pages: 435 - 444

   

4. Drotrecogin Alfa (Activated)

   • James E. Frampton
   • Rachel H. Foster

   Adis Pharmacoeconomic Drug Evaluation 22 September 2012 Pages: 445 - 476

   

5. Cost Effectiveness of Peginterferon α-2a Plus Ribavirin versus Interferon α-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C

   • Miguel Arguedas

   Correspondence 22 September 2012 Pages: 477 - 478

6. Cost Effectiveness of Peginterferon α-2a Plus Ribavirin versus Interferon α-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C. The Authors’ Reply

   • Sean D. Sullivan
   • Kavita Patel
   • Jesse Green

   Correspondence 22 September 2012 Pages: 478 - 478